Transdermal Testosterone Gel/Effect on Erection Quality as Measured by DIR

Lamm, Steven, M.D.

Status: Completed

Conditions: Hypogonadism

Treatments: Drug: AndroGel (Transdermal Testosterone Gel)

Study type: Observational

Funder types: Industry

Identifiers

NCT00425568

DIR1-SLGSC

Details and patient eligibility

About

Low testosterone may be responsible for "soft" erections in men. The purpose of our study is to see whether the daily application of a testosterone gel to raise testosterone levels will also increase the "hardness" of a man's erection.

Sex: Male

Ages: 21 to 59 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Testosterone <350 ng/dL,
• 21-59 years of age,
• BMI <30

Exclusion criteria

• Those with carcinoma of the breast or known or suspected carcinoma of the prostate or with known hypersensitivity to any of the ingredients in AndroGel.
• Men will be excluded if they have unstable angina, hypertension, diabetes, heart failure, or coronary artery disease.
• Men will agree to discontinue use of current testosterone replacement, as well as Viagra or any other PDE5 inhibitors for 30 days.